Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux
Open Access
- 1 October 2009
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 50 (10), 2046-2054
- https://doi.org/10.1194/jlr.m800579-jlr200
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated andNpc1l1−/−miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- The Cholesterol Absorption Inhibitor Ezetimibe Acts by Blocking the Sterol-Induced Internalization of NPC1L1Cell Metabolism, 2008
- Hepatic Niemann-Pick C1–like 1 regulates biliary cholesterol concentration and is a target of ezetimibeJCI Insight, 2007
- Rab8-dependent Recycling Promotes Endosomal Cholesterol Removal in Normal and Sphingolipidosis CellsMolecular Biology of the Cell, 2007
- Peroxisome proliferator-activated receptor δ (PPARδ), a novel target site for drug discovery in metabolic syndromePharmacological Research, 2006
- Regulation of Muscle Fiber Type and Running Endurance by PPARδPLoS Biology, 2004
- Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol AbsorptionScience, 2004
- Cloning of a Protein That Mediates Transcriptional Effects of Fatty Acids in PreadipocytesOnline Journal of Public Health Informatics, 1995
- Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptorsCell, 1992
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959